Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Recombinant human heparan N-sulfatase

EU orphan designation number: EU/3/08/582   
Active ingredient: Recombinant human heparan N-sulfatase
Indication: Treatment of mucopolysaccharidosis, type IIIA (Sanfilippo A syndrome)
Sponsor: Shire Pharmaceutical Development Limited
1 Kingdom Street, Paddington, London W2 6BD, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/11/2008 Orphan designation EMEA/OD/052/08 (2008)6857 of 7/11/2008
20/03/2018 Change of name and/or address of sponsor